Flurizan News
Most Popular Flurizan Story
Flurizan flunks its Phase III Alzheimer’s test
A closely watched Alzheimer's drug being developed by H. Lundbeck and its U.S. partner Myriad Genetics failed a crucial late-stage study, sending shares of Lundbeck down to a four-year low and Read more...
Latest Headlines
- December 19, 2008
- October 21, 2008
- September 11, 2008
- August 20, 2008
- July 15, 2008
- June 30, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
